1,2-Benzenediol, 4-[(1R)-1-hydroxy-2-[[4-(4-hydroxyphenyl)butyl]amino]ethyl]-
| Title | Journal |
|---|---|
| A co-module approach for elucidating drug-disease associations and revealing their molecular basis. | Bioinformatics (Oxford, England) 20120401 |
| Asymmetric hydrogenation of alpha-primary and secondary amino ketones: efficient asymmetric syntheses of (-)-arbutamine and (-)-denopamine. | Chemistry (Weinheim an der Bergstrasse, Germany) 20070101 |
| Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography. | Cardiovascular ultrasound 20070101 |
| Dobutamine stress echocardiography in healthy adult male rats. | Cardiovascular ultrasound 20050101 |
| [Comparison of usefulness of dobutamine-atropine and dobutamine-adenosine stress echocardiography in detection of coronary artery disease]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040401 |
| Myocardial perfusion scintigraphy: the evidence. | European journal of nuclear medicine and molecular imaging 20040201 |
| Sonovue improves endocardial border detection and variability in assessing wall motion score and ejection fraction during stress echocardiography. | Irish journal of medical science 20040101 |
| Effect of ligand structure on the zinc-catalyzed Henry reaction. Asymmetric syntheses of (-)-denopamine and (-)-arbutamine. | Organic letters 20020808 |
| Arbutamine stress perfusion imaging in dogs with critical coronary artery stenoses: (99m)Tc-sestamibi versus (201)Tl. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020501 |
| Pharmacologic interventions in nuclear radiology: indications, imaging protocols, and clinical results. | Radiographics : a review publication of the Radiological Society of North America, Inc 20020101 |
| Use of pharmaceuticals in noninvasive cardiovascular diagnosis. | Heart disease (Hagerstown, Md.) 20020101 |
| Assessment of adenosine, arbutamine and dobutamine as pharmacological stress agents during (99m)Tc-tetrofosmin SPECT imaging: a randomized study. | Nuclear medicine communications 20011201 |
| Pharmacological stress agents for evaluation of ischemic heart disease. | International journal of cardiology 20011201 |
| Identification of viable myocardium early after acute myocardial infarction using closed-loop arbutamine echocardiography: comparison with positron emission tomography. | Acta cardiologica 20011201 |
| Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010601 |
| Arbutamine stimulation detects viable myocardium 4 weeks after coronary occlusion. | Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20010201 |
| [Methodological aspects of performing exercise tests used in combination with perfusion scintigraphy of the myocardium]. | Terapevticheskii arkhiv 20010101 |
| Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing. | Cardiovascular drugs and therapy 19960301 |